Your browser doesn't support javascript.
loading
Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase II LOTIS-2 study.
Caimi, Paolo F; Ai, Weiyun Z; Alderuccio, Juan Pablo; Ardeshna, Kirit M; Hamadani, Mehdi; Hess, Brian; Kahl, Brad S; Radford, John; Solh, Melhem; Stathis, Anastasios; Zinzani, Pier Luigi; Wang, Ying; Qin, Yajuan; Wang, Luqiang; Xu, Zhiying Cindy; Carlo-Stella, Carmelo.
Afiliación
  • Caimi PF; Cleveland Clinic Taussig Cancer Center, Cleveland, OH. caimip@ccf.org.
  • Ai WZ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.
  • Alderuccio JP; Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.
  • Ardeshna KM; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Hamadani M; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI.
  • Hess B; Medical University of South Carolina, Charleston, SC.
  • Kahl BS; Washington University, St. Louis, MO.
  • Radford J; NIHR Clinical Research Facility, University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Solh M; Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA.
  • Stathis A; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
  • Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli," Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna.
  • Wang Y; ADC Therapeutics America, Inc., Murray Hill, NJ.
  • Qin Y; ADC Therapeutics America, Inc., Murray Hill, NJ.
  • Wang L; ADC Therapeutics America, Inc., Murray Hill, NJ.
  • Xu ZC; ADC Therapeutics America, Inc., Murray Hill, NJ.
  • Carlo-Stella C; Department of Biomedical Sciences, Humanitas University, and Department of Oncology and Hematology, Humanitas Research Hospital-IRCCS, Milano.
Haematologica ; 109(4): 1184-1193, 2024 Apr 01.
Article en En | MEDLINE | ID: mdl-37646659

Texto completo: 1 Colección: 01-internacional Asunto principal: Linfoma no Hodgkin / Linfoma de Células B Grandes Difuso Límite: Humans Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Linfoma no Hodgkin / Linfoma de Células B Grandes Difuso Límite: Humans Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article